HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Adverse reactions to antidepressants.

AbstractBACKGROUND:
Adverse drug reactions are important determinants of non-adherence to antidepressant treatment, but their assessment is complicated by overlap with depressive symptoms and lack of reliable self-report measures.
AIMS:
To evaluate a simple self-report measure and describe adverse reactions to antidepressants in a large sample.
METHOD:
The newly developed self-report Antidepressant Side-Effect Checklist and the psychiatrist-rated UKU Side Effect Rating Scale were repeatedly administered to 811 adult participants with depression in a part-randomised multicentre open-label study comparing escitalopram and nortriptyline.
RESULTS:
There was good agreement between self-report and psychiatrists' ratings. Most complaints listed as adverse reactions in people with depression were more common when they were medication-free rather than during their treatment with antidepressants. Dry mouth (74%), constipation (33%) and weight gain (15%) were associated with nortriptyline treatment. Diarrhoea (9%), insomnia (36%) and yawning (16%) were more common during treatment with escitalopram. Problems with urination and drowsiness predicted discontinuation of nortriptyline. Diarrhoea and decreased appetite predicted discontinuation of escitalopram.
CONCLUSIONS:
Adverse reactions to antidepressants can be reliably assessed by self-report. Attention to specific adverse reactions may improve adherence to antidepressant treatment.
AuthorsRudolf Uher, Anne Farmer, Neven Henigsberg, Marcella Rietschel, Ole Mors, Wolfgang Maier, Dejan Kozel, Joanna Hauser, Daniel Souery, Anna Placentino, Jana Strohmaier, Nader Perroud, Astrid Zobel, Aleksandra Rajewska-Rager, Moica Z Dernovsek, Erik Roj Larsen, Petra Kalember, Caterina Giovannini, Mara Barreto, Peter McGuffin, Katherine J Aitchison
JournalThe British journal of psychiatry : the journal of mental science (Br J Psychiatry) Vol. 195 Issue 3 Pg. 202-10 (Sep 2009) ISSN: 1472-1465 [Electronic] England
PMID19721108 (Publication Type: Journal Article, Multicenter Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)
Chemical References
  • Antidepressive Agents
  • Citalopram
  • Nortriptyline
Topics
  • Adult
  • Aged
  • Antidepressive Agents (adverse effects)
  • Citalopram (adverse effects)
  • Depressive Disorder (drug therapy, psychology)
  • Female
  • Humans
  • Male
  • Middle Aged
  • Nortriptyline (adverse effects)
  • Patient Acceptance of Health Care (psychology, statistics & numerical data)
  • Psychiatric Status Rating Scales
  • Severity of Illness Index
  • Statistics as Topic
  • Surveys and Questionnaires (standards)
  • Time Factors
  • Urinary Retention (chemically induced)
  • Xerostomia (chemically induced)
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: